Aspira Women’s Health Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Aspira Women's Health Inc. reported Cash And Cash Equivalents At Carrying Value of $1.77 million for the year ending 2024.

  • Aspira Women's Health Inc. showed a decrease of -31.9% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from Aspira Women's Health Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
  • XBRL data for this metric is available from 2009 to 2024 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2009 to 2024), Aspira Women's Health Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 48.6%.
  • Historical annual values: Fiscal year 2024: $1.77 million | Fiscal year 2023: $2.60 million | Fiscal year 2022: $13.31 million | Fiscal year 2021: $37.18 million | Fiscal year 2020: $16.63 million | Fiscal year 2017: $5.54 million | Fiscal year 2016: $5.24 million | Fiscal year 2015: $18.64 million | Fiscal year 2014: $22.97 million | Fiscal year 2013: $29.50 million | Fiscal year 2012: $8.01 million | Fiscal year 2011: $22.48 million | Fiscal year 2010: $22.91 million | Fiscal year 2009: $3.44 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: